Page last updated: 2024-11-08

xylobiose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

xylobiose: RN given refers to D-xylose [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

xylobiose : A glycosylxylose that is D-xylopyranose having a beta-D-xylopyranosyl residue attached at position 4 via a glycosidic bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439538
CHEBI ID28309
MeSH IDM0045146

Synonyms (36)

Synonym
1,4-beta-xylobiose
4-o-beta-d-xylopyranosyl-d-xylose
xylobiose
C01630
6860-47-5
AC1L97JQ ,
(2s,3r,4s,5r)-2-[(3r,4r,5r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol
(1,4)-beta-xylobiose
BMSE000793 ,
BMSE000823 ,
1,4-d-xylobiose
(xyl)2
S3253
CTK8F3007 ,
4-o-beta-d-xylopyranosyl-d-xylopyranose
xylbeta(1->4)xyl
beta-d-xylopyranosyl-(1->4)-d-xylopyranose
beta-d-xylp-(1->4)-d-xylp
beta-d-xyl-(1->4)-d-xyl
xylbeta(1,4)xyl
d-xylobiose
CHEBI:28309
W-203525
AC-34509
(2s,3r,4s,5r)-2-[(3r,4r,5r)-4,5,6-trihydroxytetrahydropyran-3-yl]oxytetrahydropyran-3,4,5-triol
AKOS030228569
mfcd00135984
(3r,4r,5r)-5-((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2,3,4-triol
D78467
4-o-(b-d-xylopyranosyl)-d-xylose
AS-56649
(2s,3r,4s,5r)-2-{[(3r,4r,5r)-4,5,6-trihydroxyoxan-3-yl]oxy}oxane-3,4,5-triol
83113-52-4
(3r,4r,5r)-5-(((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2,3,4-triol
1,4--d-xylobiose;1,4-d-xylobiose
CS-0455833

Research Excerpts

Overview

Xylobiose is a prebiotic sugar that has applications in functional foods.

ExcerptReferenceRelevance
"Xylobiose is a prebiotic sugar that has applications in functional foods. "( The first crystal structure of a xylobiose-bound xylobiohydrolase with high functional specificity from the bacterial glycoside hydrolase family 30, subfamily 10.
Crooks, C; Joachimiak, A; Kim, Y; St John, FJ; Tan, K, 2022
)
2.45

Dosage Studied

ExcerptRelevanceReference
" Satisfactory cellulose conversion could be achieved by increasing the enzyme dosage in order to overcome the end-product inhibition, while the complexity of hemicellulose structure imposes the presence of specific enzyme activities in the enzyme mixture used."( Factors affecting cellulose and hemicellulose hydrolysis of alkali treated brewers spent grain by Fusarium oxysporum enzyme extract.
Christakopoulos, P; Katapodis, P; Xiros, C, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
glycosylxyloseAny xylose in which one of the hydroxy groups has undergone formal glycosylation.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (128)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (3.91)18.7374
1990's12 (9.38)18.2507
2000's39 (30.47)29.6817
2010's57 (44.53)24.3611
2020's15 (11.72)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.04 (24.57)
Research Supply Index4.88 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index40.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other130 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]